“Efficacy and Safety of Abrocitinib Versus Dupilumab in Patients Who Self-Identified As Having Skin of Color: A Post Hoc Analysis of JADE COMPARE”. SKIN The Journal of Cutaneous Medicine 10, no. 2 (March 10, 2026): s733. Accessed April 27, 2026. https://skin.dermsquared.com/skin/article/view/4026.